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Abstract 
Background: Obesity is frequently referred to as an independent risk factor for high 
blood pressure and hypertension is very prevalent among obese people. The aims of this 
study were: to compare office-based and 24h blood pressure (BP) and its circadian 
pattern between lean and obese women; to study correlations between BP, insulin 
resistance (IR) and markers of subclinical inflammation/early atherosclerosis. 
Material and methods: Eighty-eight lean and 107 otherwise healthy obese women 
were characterized for anthropometrics, BP (office-based determinations and 24h 
ABPM) and for glucose, insulin, triglycerides, inteleukin 6 (IL-6), tumor necrosis factor 
alpha (TNF-α), high-sensitivity C reactive protein (hs-CRP), retinol-binding protein 4 
(RBP-4), leptin, adiponectin, resistin, monocyte chemoattractant protein 1 (MCP-1), 
intercellular adhesion molecule 1 (ICAM-1), and vascular-cellular adhesion molecule 1 
(VCAM-1). Insulin resistance was determined by homeostasis model assessment of 
insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), 
and McAuley indexes (also Matsuda in obese). 
Results: Obese group presented higher office-based systolic/diastolic BP, systolic 
ambulatory blood pressure monitoring (ABPM), and more non-dippers. HOMA-IR and 
body fat was correlated to systolic (r2 = 0.176) and glucose to diastolic (p = 0.008; r = 
0.256) ABPM. Age, QUICKI, and TNF-α was correlated with dipping (r2 = 0.172); 
adiponectin, age, BMI, and glucose to systolic (r2 = 0.226) and diastolic (r2 = 0.215) 
office-based BP. Concerning lean women, MCP-1 was associated with diastolic ABPM 
(p = 0.013; r = 0.267). Systolic office-based BP was associated with waist-to-hip ratio 
(p = 0.01; r = 0.273); this and RBP-4 was correlated with office-based diastolic BP (r2 = 
0.12). 
Conclusion: Although relatively healthy, obese women present higher BP than lean. 
Anthropometrics, IR, and fasting glucose all influence BP in obesity; additionally, IR is 
involved in non-dipping. No strong correlation exists between BP/dipping and 
subclinical inflammation in either group of women 
Key words: obesity; hypertension; cardiovascular diseases; dipping; subclinical 
inflammation 
 
Introduction 
Obesity is frequently referred to as an independent risk factor for high blood pressure 
and hypertension is very prevalent among obese people [1]. Compared to lean 
individuals, the National Health and Nutrition Examination Survey III Study showed 
that the odds ratio for the presence of hypertension was 1.7 for overweight, 2.6 for class 
I obesity, 3.7 for class II obesity and 4.8 for class III obesity [2]. Being both obesity and 
hypertension independent cardiovascular risk factors, obese hypertensive patients 
represent very high-risk individuals [3]. In the presence of excessive fat mass, the 
dysfunctional adipose tissue produces higher levels of adipokines that may interfere at 
several steps of blood pressure control [4–7]. On the other hand adiponectin, an 
adipokine with reported beneficial effects on blood pressure lowering, is synthesized at 
lower levels [8–10]. Moreover, obesity is associated with a hyperactivation of the 
sympathetic nervous system, which contributes both to an increase in blood pressure 
and to the blockade of the normal nocturnal fall in blood pressure [5, 11–13]. The aim 
of this study was to compare classic office-based and 24h mean blood pressure and its 
circadian pattern between obese otherwise healthy and lean women without known 
history of hypertension. Secondarily, we aimed to study correlations of blood pressure, 
determined by the two methods, with insulin resistance, markers of subclinical 
inflammation and early atherosclerosis in each group of women. 
 
Material and methods 
Subjects 
The obese group consisted in 107 obese Caucasian premenopausal women who attended 
the obesity outpatient clinic at the Curry Cabral Hospital — C.H.L.C. (Lisbon, 
Portugal). Their age ranged from 18 to 50 years old and their body mass index (BMI) 
was ≥ 30 kg/m2. All of them referred less than 10% variation on their body weight in the 
previous year. 
The control group consisted in 88 healthy Caucasian premenopausal women, who either 
attended to a routine health check or belonged to the health care staff of Curry Cabral 
Hospital — C.H.L.C. They were aged from 18 to 50 years old, body mass index (BMI) 
from 18,5 to 24,9 kg/m2, and referring less than 10% variation on their body weight in 
the previous year.  
No woman was pregnant or had been pregnant in the precedent 12 months. We 
considered only women without previous diagnosis of any acute/chronic health 
conditions (except obesity for the obese group), namely previous diagnosis of 
hypertension. No woman was on any pharmacological regimen (except for oral 
contraceptives) or took any sporadic drug in the previous 7 days.  
The study was conducted following the approval of the institutional scientific and 
ethical boards accordingly to the standards of the Declaration of Helsinki. Additionally, 
an informed consent was signed by all participants. 
 
Clinical evaluation 
Each woman was characterized for total body weight, BMI, waist and hip 
circumferences, and waist-to-hip ratio. The total body fat mass (absolute and percentage 
of body weight) was assessed by bioelectrical impedance (Tanita TBF-300A®, Tanita 
Europe B.V., Hoofddorp, The Netherlands).  
Office-based blood pressure was assessed by the mean value of 2 determinations at the 
left arm, in the standard recommended conditions with a 5 minutes interval, using an 
electronic device with appropriated sized cuffs (CASMED® 740 monitor, CAS Medical 
Systems Inc, Branford, CT, USA). Women were classified as hypertensive if the mean 
values were ≥ 140 mm Hg for systolic or ≥ 90 mm Hg for diastolic blood pressure. 
ABPM was performed during a 24h period, in a regular day, with registrations every 30 
minutes during daytime (from 07:00 am to 11:00 pm) and every hour for the night-time 
(from 11:00 pm to 07:00 am) with a portable electronic device (SpaceLabs 90207® 
monitor, SpaceLabs Healthcare, Issaquah, WA, USA) and appropriated sized cuffs. The 
device established the mean values of systolic and diastolic blood pressure for daytime, 
night-time and the overall 24h period. Women were classified as hypertensive if mean 
values were ≥ 130/80 mm Hg for the overall 24h, ≥ 135/85 mm Hg for the daytime or ≥ 
120/70 mm Hg for the night-time periods accordingly to the European Society of 
Hypertension and European Society of Cardiology criteria [11]. They were considered 
as dippers if a ≥ 10% decrease in mean night-time blood pressure occurred compared to 
mean daytime blood pressure. 
Women answered a small questionnaire regarding smoking status, use of oral 
contraceptives and the existence of diagnosed hypertension among first degree relatives.  
 
Blood sample collection and measurements 
After a period of 10h fasting, a venous blood sample was collected from obese and lean 
women for assessment of glucose, insulin, triglycerides, interleukin 6 (IL-6), tumor 
necrosis factor alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), retinol-
binding protein 4 (RBP-4), leptin, adiponectin, resistin, monocyte chemoattractant 
protein 1 (MCP-1), intercellular adhesion molecule 1 (ICAM-1), and vascular-cellular 
adhesion molecule 1 (VCAM-1). Additionally, a classic 75g oral glucose tolerance test 
was performed with blood samples collected after 30, 60, 90, and 120 minutes for the 
assessment of glucose and insulin. Serum samples were obtained by low-speed 
centrifugation, stored at a –80ºC ultra-freezer, and thawed just before each assay. 
Glucose and triglycerides were determined by automated chemistry analyzer (Vitros® 
5,1 FS Chemistry System, Ortho-Clinical Diagnosis Inc, Rochester, NY, USA) and hs-
CRP concentration by a nephelometer system using CardioPhase® hsCRP assay 
(Siemens Healthcare Diagnostics Inc, Tarrytown, NY, USA). Leptinemia was assessed 
by radioimmunoassay technique (EMD Millipore Corporation, Billerica, MA, USA). 
Insulinemia was determined by a chemiluminescent immunometric technique 
(IMMULITE® 2000 Immunoassay System, Siemens Healthcare Diagnostics Inc, 
Tarrytown, NY, USA). Serum IL-6, TNF-α, RBP-4, adiponectin, resistin, MCP-1, 
ICAM-1, and VCAM-1 concentrations were all measured by enzyme-linked 
immunosorbent assay following the manufacturer’s instructions (R&D Systems Inc., 
Minneapolis, MN, USA). Insulin resistance/sensitivity was assessed by the application 
of four mathematical equations as follows: 
 homeostasis model assessment of insulin resistance (HOMA-IR) using 
the formula: fasting insulin in μU/mL × fasting glucose in mg/dL/405;  
 quantitative insulin sensitivity check index (QUICKI): 1/[log(fasting 
insulin in μU/mL) + log(fasting glucose in mg/dL)];  
 McAuley index (for assessment of insulin sensitivity): exp[2.63 – 0.28 x 
log(fasting insulin in μU/mL – 0.31 x log(fasting triglycerides in 
mg/dl/87.72];  
 Matsuda formula (also an index of insulin sensitivity): 
10.000/SqRt[fasting insulin in μU/mL × fasting glucose in mg/dL x 
mean (insulin at 0, 30, 60, 90, and 120 min in μU/mL) × mean (glucose 
at 0, 30, 60, 90, and 120 min in mg/dL]. 
 
Statistical analysis 
Data are reported as mean ± SD. Comparisons between groups were made by t-Student 
test. The interactions between non-continuous parameters were analyzed by 2 test. 
Simple associations were tested by Spearman r test and multiple regression analysis was 
carried out by the use of a forward stepwise model. A p value < 0.05 was considered 
statistically significant. All determinations were performed using SPSS software, 
version 18.0 (IBM Corporation, Armonk, NY, USA). 
 
Results 
The characterization of obese and lean groups is depicted in Table 1. In the obese group, 
office-based systolic blood pressure was significantly correlated to systolic blood 
pressure values obtained by ABPM in daytime (p < 0.001; r = 0.539), night-time (p < 
0.001; r = 0.386) and 24h period (p < 0.001; r = 0.561). Identical results were observed 
between mean diastolic blood pressure at the office and in ABPM in daytime (p < 
0.001; r = 0.717), night-time (p = 0.002; r = 0.295) and 24h period (p < 0.001; r = 0.43). 
Also in obese women, there was a significant inverse association of age with insulin 
resistance determined by HOMA-IR (p = 0.042; r = –0.197) and a trend for the inverse 
correlation with BMI (p = 0.056; r = –0.186); age was directly associated with all 
insulin sensitivity indexes: QUICKI (p = 0.009; r = 0.253), McAuley index (p = 0.007; r 
= 0.261), and Matsuda formula (p = 0.01; r = 0.248). 
Less strong correlations were observed in the lean women between office-based systolic 
blood pressure and systolic blood pressure by ABPM in daytime (p = 0.001; r = 0.359), 
night-time (p = 0.015; r = 0.26) and 24h period (p = 0.002; r = 0.327). The same was 
observed concerning association of diastolic office-based blood pressure and diastolic 
ABPM mean values in daytime (p = 0.009; r = 0.278), night-time (p = 0.013; r = 0.264) 
and 24h (p = 0.015; r = 0.258). 
For both groups of women, the association between office-based blood pressure and 24h 
values in ABPM for systolic and diastolic blood pressure is exposed graphically in 
Figures 1 and 2, respectively. 
Hypertension based on office measurements of blood pressure was more prevalent 
among obese women (Tab. 2), but that difference was not observed on ambulatory 
blood pressure monitoring (Tab. 3). Likewise, no difference between obese and lean 
groups was observed if we considered ABPM criteria for hypertension in daytime 
(16.8% vs. 15.9%), night-time (31.1% vs. 27.6%) and 24h (19.6% vs. 18.2%) periods 
separately. When comparing those diagnosed for hypertension by office-based 
measurements with those based on ABPM, different populations were found (Tab. 4). 
That was also true if we compared office-based hypertensive women with those with 
daytime (p < 0.001), night-time (p = 0.012) and 24h (p < 0.001) criteria for 
hypertension. 
Non-dipper pattern of blood pressure variation was more prevalent in obese than in lean 
women (39.6% vs. 24.1%; p = 0.022). Considering each group of women, the 
prevalence of non-dippers was lower in those who fitted the criteria for night-time 
hypertension than in those who did not, either in obese (p = 0.001) or in lean women (p 
= 0.018). 
In obese women several direct correlations exist between blood pressure, insulin 
resistance and some markers of subclinical inflammation or atherogenesis. Moreover, 
some particular inverse correlations were present between some of those parameters and 
the degree of nocturnal fall in blood pressure. By a stepwise multiple regression analysis 
HOMA-IR and body fat percentage were found to be independently associated to 24h 
(r2 = 0.176) and daytime (r2 = 0.111) systolic blood pressure; HOMA-IR and waist 
circumference were independently associated with night-time systolic blood pressure (r2 
= 0.202). Fasting glucose was associated with daytime (p = 0.039; r = 0.199) and 24h 
diastolic blood pressure (p = 0.008; r = 0.256). Night-time diastolic blood pressure was 
correlated with HOMA-IR (p = 0.003; r = 0.286) and QUICKI (p = 0.017; r = –0.231). 
By a stepwise multiple regression analysis, it was shown that TNF-α levels (inversely), 
age and QUICKI (directly) were all independently correlated with the dipping 
phenomenon (r2 = 0.172). Adiponectin circulating levels (inversely), age, BMI, and 
fasting glucose (directly) were all independently correlated to systolic (r2 = 0.226) and 
diastolic (r2 = 0.215) office-based blood pressure. 
By contrast, among lean women an independent association exists between MCP-1 
circulating levels and diastolic blood pressure in daytime (p = 0.013; r = 0.269) and 24h 
period (p = 0.013; r = 0.267) ABPM. Systolic office-based blood pressure was 
associated with waist-to-hip ratio (p = 0.01; r = 0.273); waist-to-hip ratio and RBP-4 
circulating levels were independently associated with diastolic office-based blood 
pressure (r2 = 0.12). In this group of women, no association was found for the dipping 
phenomenon with any of the parameters considered in this study. 
 
Discussion 
As classically described, obesity is associated with high blood pressure [1, 2]. That was 
also shown in this study for office-based systolic and diastolic blood pressure and for 
systolic blood pressure in all periods considered in ABPM. Although a high correlation 
was present between office-based and ABPM, it was found a significant difference in 
hypertension prevalence between obese and lean women for office-based criteria but not 
for ABPM criteria. In concordance to these data, we confirmed that the group of women 
diagnosed with hypertension by one criterion does not fit in the hypertension definition 
by the other. For the definition of daytime and night-time we considered fixed 
schedules. One possibility for the dissimilarity between criteria could be the fact that 
some women had daytime-like activities over 11:00 pm or before 07:00 am. If it would 
be the case, mean night-time blood pressure values would be expected to increase 
leading to a higher prevalence of night-time hypertension and exaggerating 
hypertension rates based in ABPM [15]. Nevertheless, that explanation does not appear 
to fit; if we compared women with office-based hypertension with those with 
hypertension criteria based on daytime, the difference was even greater (p < 0.001) than 
if we compared with those with night-time hypertension (p = 0.012). 
All the factors that were independently associated with office-based blood pressure 
values in obese women (i.e. age, BMI, fasting glucose, and adiponectin), and that 
explains more than one fifth of its variation, are in line with previous reports in the 
literature [5, 16–18]. Also based on ABPM, it was shown a direct association of systolic 
blood pressure with anthropometrics. The net association between fasting glucose levels 
and diastolic blood pressure is concordant with the close relationship that exists between 
hypertension and glucose intolerance states. Hypertension is more prevalent in 
individuals with type 2 diabetes and intermediate hyperglycemia and these conditions 
are more prevalent among individuals diagnosed with hypertension [17–19]. 
Independently from anthropometrics, insulin resistance was also directly associated with 
blood pressure values in obese women. This is in line with the evidence of insulin 
resistance per se as a contributing factor for hypertension. There are several mechanistic 
explanations for the association between insulin resistance and blood pressure increase; 
one of those mechanisms involves sympathetic activation. [20]. The greater sympathetic 
activity in insulin resistant women would explain the higher night-time blood pressure 
values and the non-dipping pattern observed. Non-dippers have also been reported to be 
more prevalent in conditions characterized by insulin resistance [21].  
The inverse independent association of TNF-α with the dipping status would be 
expected in the context of a higher atherogenic-related subclinical inflammation state 
[22]. Assuming non-dipper status as a cardiovascular risk factor it would be logical to 
find higher levels of several atherogenic markers, but it was not the case. Another 
possible explanation for the inverse association of TNF-α with dipping phenomenon 
could be through induction of insulin resistance [23]. Nevertheless, that association is 
independent of insulin sensitivity and no association could be found between TNF-α 
and insulin resistance indexes in this study. On the other hand, TNF-α itself could have 
some direct effect on vasculature inducing endothelial dysfunction and a decrease in 
nitric oxide synthesis as previously demonstrated in rats [24, 25].  
Aging is characterized by an increase in sympathetic activity [26]. However, in this 
study it was found an inverse association between age and dipping in obese women. It is 
true that there was a trend for the inverse correlation of age with BMI and that age was 
directly associated with insulin sensitivity. Nevertheless, the association of age with the 
dipping status was independent of those two parameters. For the inclusion criteria only 
women without any known health condition (other than obesity) were accepted. The age 
ranged from 18 to 50 years old but it was especially difficult to find obese women above 
the age of 35 (and a more prolonged history of obesity) with no known comorbidities. 
Perhaps those older obese women selected belong to the so-called relatively benign 
obesity or metabolically healthy but obese individuals, i.e. those with obesity but 
without the metabolic and cardiovascular risks as expected for the degree of excessive 
body fat [27, 28]. 
Opposite to the obese group, in lean women all the above associations were missing. 
That could be the case because most of the parameters shown to be associated with 
blood pressure parameters in the obese group were lower in lean women. Thus there 
was still no deleterious involvement on blood pressure control. One exception was 
anthropometry, confirming that it exerts an effect on blood pressure even in the absence 
of excessive body fat mass. 
Although an association exists between mean blood pressure levels in ABPM and those 
obtained by standard measurement in the office setting, whether we use one or the other 
for the diagnosis of hypertension we are identifying different groups of women. In 
obese women, anthropometrics and insulin resistance are main determinants of blood 
pressure in ABPM. Age, anthropometrics, fasting glucose, and adiponectin circulating 
levels all influence office-based blood pressure levels, explaining a little more than 20% 
of it. On the other hand, age, insulin resistance and TNF-α levels are all independent 
determinants of blood pressure fall during night-time. Even though assuming a lower 
cardiovascular risk compared to the classic obesity, metabolically healthy but obese 
women present higher blood pressure (essentially systolic blood pressure). However, no 
strong correlation exists between blood pressure or the dipping phenomenon and 
subclinical inflammation or markers of atherosclerosis activity either in lean or in 
metabolically healthy but obese women. 
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Table 1. Characteristics of lean and obese women (mean ± SD) 
 Lean women Obese women p value 
N 88 107  
Age (years) 33.8 ± 8.4 34.5 ± 8.3 0.561 
BMI [kg/m2] 
21.5 ± 1.7 43.5 ± 7.5 
 < 
0.001 
Total body weight [kg] 
56.0 ± 5.3 111.2 ± 20.8 
 < 
0.001 
Total body fat [kg] 
14.2 ± 3.6 53.7 ± 14.5 
 < 
0.001 
Percentage of body fat (%) 
25.0 ± 4.7 47.7 ± 5.1 
 < 
0.001 
Waist circumference [cm] 
71.9 ± 6.0 117.3 ± 14.3 
 < 
0.001 
Hip circumference [cm] 
97.6 ± 4.6 134.0 ± 12.6 
 < 
0.001 
Waist-to-hip ratio 
0.74 ± 0.05 0.88 ± 0.08 
 < 
0.001 
Office systolic BP [mm Hg] 
108.6 ± 12.1 124.7 ± 16.3 
 < 
0.001 
Office diastolic BP [mm Hg] 
69.3 ± 9.7 79.5 ± 10.3 
 < 
0.001 
ABPM systolic BP in 24h [mm Hg] 
115.9 ± 9.6 121.0 ± 9.1 
 < 
0.001 
ABPM diastolic BP in 24h [mm Hg] 72.5 ± 7.2 72.6 ± 6.7 0.889 
ABPM systolic BP in daytime [mm Hg] 119.2 ± 9.6 124.0 ± 9.7 0.001 
ABPM diastolic BP in daytime [mm Hg] 75.9 ± 7.2 75.9 ± 7.5 0.973 
ABPM systolic BP in night-time [mm Hg] 
106.6 ± 10.6 112.4 ± 11.0 
 < 
0.001 
ABPM diastolic BP in night-time [mm 
Hg] 
62.7 ± 7.6 63.6 ± 8.2 0.447 
Fasting glucose [mg/dL] 
81.0 ± 7.2 93.3 ± 29.2 
 < 
0.001 
Fasting insulin [μUI/mL]  5.9 ± 3.8 17.7 ± 11.4  < 
0.001 
Triglycerides [mg/dL] 
79.8 ± 29.7 120.6 ± 78.3 
 < 
0.001 
Interleukin-6 [pg/mL] 
1.39 ± 1.33 2.38 ± 1.66 
 < 
0.001 
TNF-α [pg/mL] 1.31 ± 0.81 1.38 ± 0.89 0.579 
High-sensitivity C reactive protein 
[mg/dL] 
0.22 ± 0.31 0.96 ± 0.76 
 < 
0.001 
RBP-4 [ng/mL] 41.3 ± 12.5 34.2 ± 16.4 0.001 
Leptin [ng/mL] 
10.5 ± 5.8 36.8 ± 14.9 
 < 
0.001 
Adiponectin [μg/mL] 
12.3 ± 5.1 6.9 ± 3.3 
 < 
0.001 
Resistin [ng/mL] 19.2 ± 10.7 19.2 ± 9.6 0.99 
MCP-1 [pg/mL] 324.7 ± 102.2 374.5 ± 129.6 0.003 
ICAM-1 [ng/mL] 228.1 ± 54.2 245.8 ± 72.8 0.061 
VCAM-1 [ng/mL] 506.7 ± 182.6 496.9 ± 186.1 0.714 
HOMA-IR 
1.18 ± 0.76 4.31 ± 3.56 
 < 
0.001 
QUICKI  
0.17 ± 0.02 0.14 ± 0.01 
 < 
0.001 
McAuley index 
9.50 ± 1.96 6.4 ± 1.7 
 < 
0.001 
Matsuda formula ND 3.92 ± 2.79 - 
Women on oral contraceptives (%) 50.0 (44/88) 46.7 (50/107) 0.649 
Current smokers (%) 
35.2 (31/88) 12.1 (13/107) 
 < 
0.001 
Diagnosed hypertension in first degree 
relatives (%) 
55.7 (44/79)* 54.1 (46/85)* 0.839 
ND — not determined; BMI — body mass index; ABPM — ambulatory blood pressure 
monitoring; TNF-α — tumor necrosis factor alpha; hs-CRP — high-sensitivity C reactive 
protein RBP-4 — retinol-binding protein 4; MCP-1 — monocyte chemoattractant protein 1; 
ICAM-1 — intercellular adhesion molecule 1; VCAM-1 — vascular-cellular adhesion molecule 
1; HOMA-IR — homeostasis model assessment of insulin resistance; QUICKI — quantitative 
insulin sensitivity check index  
*Data concerning to the presence/absence of diagnosed hypertension in first degree relatives 
could not be obtained in 9 lean and in 22 obese women 
 
 Table 2. Obese and lean women meeting criteria for hypertension by office-based blood 
pressure 
p < 0.001 
Office-based blood pressure 
criteria for hypertension 
 
Yes No Total 
Group 
Obese women 
28 
(26.2%) 
79 
(73.8%) 
107 
(100%) 
Lean women 
3 
(3.4%) 
85 
(96.6%) 
88 
(100%) 
 Total 
31 
(15.9%) 
164 
(84.1%) 
195 
(100%) 
 
 
 
Table 3. Obese and lean women meeting criteria for hypertension by ambulatory blood 
pressure monitoring 
p = 0.199 
Ambulatory blood pressure 
monitoring criteria for 
hypertension 
 
Yes No Total 
Group 
Obese women 
41 
(38.3%) 
66 
(61.7%) 
107 
(100%) 
Lean women 
26 
(29.5%) 
62 
(70.5%) 
88 
(100%) 
 Total 
67 
(34.4%) 
128 
(65.6%) 
195 
(100%) 
 
 
Table 4. Comparison of hypertensive groups by office-based and ambulatory blood 
pressure monitoring considering only obese women (A) and both groups together (B). 
A — obese women 
p = 0.005 Ambulatory blood pressure  
monitoring criteria for 
hypertension 
Yes No Total 
Office-based 
blood pressure 
criteria for 
hypertension 
Yes 
17 
(15.9%) 
11 
(10.3%) 
28 
(26.2%) 
No 
24 
(22.4%) 
55 
(51.4%) 
79 
(73.8%) 
 Total 
41 
(38.3%) 
66 
(61.7%) 
107 
(100%) 
 
B — both groups together 
p = 0.001 
Ambulatory blood pressure 
monitoring criteria for 
hypertension 
 
Yes No Total 
Office-based 
blood pressure 
criteria for 
hypertension 
Yes 
19 
(9.8%) 
12 
(6.1%) 
31 
(15.9%) 
No 
48 
(24.6%) 
116 
(59.5%) 
164 
(84.1%) 
 Total 
67 
(34.4%) 
128 
(65.6%) 
195 
(100%) 
 
 
Figure 1. Correlation of mean systolic office-based blood pressure and mean values in 
24h ambulatory blood pressure monitoring, in obese and normal-weight women 
  
Figure 2. Correlation of mean diastolic office-based blood pressure and mean values in 
24h ambulatory blood pressure monitoring, in obese and normal-weight women 
  
 
